| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Sir Quinton Hazell Molecular Medicine Research Centre (D.K.G., Y.D., H.S.R., E.K., A.J.E., E.W.H.) Department of Biological Sciences University of Warwick Coventry, CV4 7AL, United Kingdom The Johns Hopkins University School of Medicine (M.A.L.) Division of Pediatric Endocrinology Department of Pediatrics Baltimore, Maryland 21287
CRH exerts its actions via activation of specific
G protein-coupled receptors, which exist in two types, CRH-R1 and
CRH-R2, and arise from different genes with multiple spliced variants.
RT-PCR amplification of CRH receptor sequences from human
myometrium and fetal membranes yielded cDNAs that encode a novel CRH-R
type 1 spliced variant. This variant (CRH-R1d) is present in the human
pregnant myometrium at term only, which suggests a physiologically
important role at the end of human pregnancy and labor. The amino acid
sequence of CRH-R1d is identical to the CRH-R1
receptor except that
it contains an exon deletion resulting in the absence of 14 amino acids
in the predicted seventh transmembrane domain. Binding studies in
HEK-293 cells stably expressing the CRH-R1d or CRH-R1
receptors
revealed that the deletion does not change the binding characteristics
of the variant receptor. In contrast, studies on the G protein
activation demonstrated that CRH-R1d is not well coupled to the four
subtypes of G proteins (Gs,
Gi, Go,
Gq) that CRH-R1
can activate. These data
suggest that although the deleted segment is not important for CRH
binding, it plays a crucial role in CRH receptor signal
transduction.
Second messenger studies of the variant receptor showed that CRH and
CRH-like peptides can stimulate the adenylate cyclase system, with
reduced sensitivity and potency by 10-fold compared with the CRH-R1
.
Furthermore, CRH failed to stimulate inositol trisphosphate production.
Coexpression studies between the CRH-R1d or CRH-R1
showed that
this receptor does not play a role as a dominant negative receptor for
CRH.
This article has been cited by other articles:
![]() |
Dan Jin, Ping He, Xingji You, Xiaoyan Zhu, Ling Dai, Qian He, Chunmin Liu, Ning Hui, Jinyan Sha, and Xin Ni Expression of Corticotropin-Releasing Hormone Receptor Type 1 and Type 2 in Human Pregnant Myometrium Reproductive Sciences, September 1, 2007; 14(6): 568 - 577. [Abstract] [PDF] |
||||
![]() |
D. Markovic, M. Vatish, M. Gu, D. Slater, R. Newton, H. Lehnert, and D. K. Grammatopoulos The Onset of Labor Alters Corticotropin-Releasing Hormone Type 1 Receptor Variant Expression in Human Myometrium: Putative Role of Interleukin-1{beta} Endocrinology, July 1, 2007; 148(7): 3205 - 3213. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. V. Wu, P.-q. Yuan, L. Wang, Y. L. Peng, C.-Y. Chen, and Y. Tache Identification and Characterization of Multiple Corticotropin-Releasing Factor Type 2 Receptor Isoforms in the Rat Esophagus Endocrinology, April 1, 2007; 148(4): 1675 - 1687. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Yang, X. You, X. Tang, L. Gao, and X. Ni Corticotropin-releasing hormone inhibits progesterone production in cultured human placental trophoblasts J. Mol. Endocrinol., December 1, 2006; 37(3): 533 - 540. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Markovic, N. Papadopoulou, T. Teli, H. Randeva, M. A. Levine, E. W. Hillhouse, and D. K. Grammatopoulos Differential Responses of Corticotropin-Releasing Hormone Receptor Type 1 Variants to Protein Kinase C Phosphorylation J. Pharmacol. Exp. Ther., December 1, 2006; 319(3): 1032 - 1042. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Mastorakos, E. I Karoutsou, and M. Mizamtsidi Corticotropin releasing hormone and the immune/inflammatory response Eur. J. Endocrinol., November 1, 2006; 155(suppl_1): S77 - S84. [Abstract] [Full Text] [PDF] |
||||
![]() |
E Zoumakis, D K Grammatopoulos, and G P Chrousos Corticotropin-releasing hormone receptor antagonists Eur. J. Endocrinol., November 1, 2006; 155(suppl_1): S85 - S91. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. You, R. Yang, X. Tang, L. Gao, and X. Ni Corticotropin-Releasing Hormone Stimulates Estrogen Biosynthesis in Cultured Human Placental Trophoblasts Biol Reprod, June 1, 2006; 74(6): 1067 - 1072. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. W. Hillhouse and D. K. Grammatopoulos The Molecular Mechanisms Underlying the Regulation of the Biological Activity of Corticotropin-Releasing Hormone Receptors: Implications for Physiology and Pathophysiology Endocr. Rev., May 1, 2006; 27(3): 260 - 286. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Li and J. R. G. Challis Corticotropin-Releasing Hormone and Urocortin Induce Secretion of Matrix Metalloproteinase-9 (MMP-9) without Change in Tissue Inhibitors of MMP-1 by Cultured Cells from Human Placenta and Fetal Membranes J. Clin. Endocrinol. Metab., December 1, 2005; 90(12): 6569 - 6574. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Sirianni, B. A. Mayhew, B. R. Carr, C. R. Parker Jr., and W. E. Rainey Corticotropin-Releasing Hormone (CRH) and Urocortin Act through Type 1 CRH Receptors to Stimulate Dehydroepiandrosterone Sulfate Production in Human Fetal Adrenal Cells J. Clin. Endocrinol. Metab., September 1, 2005; 90(9): 5393 - 5400. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Seck, M. Pellegrini, A. M. Florea, V. Grignoux, R. Baron, D. F. Mierke, and W. C. Horne The {Delta}e13 Isoform of the Calcitonin Receptor Forms a Six-Transmembrane Domain Receptor with Dominant-Negative Effects on Receptor Surface Expression and Signaling Mol. Endocrinol., August 1, 2005; 19(8): 2132 - 2144. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Cao, N. Papadopoulou, D. Kempuraj, W. S. Boucher, K. Sugimoto, C. L. Cetrulo, and T. C. Theoharides Human Mast Cells Express Corticotropin-Releasing Hormone (CRH) Receptors and CRH Leads to Selective Secretion of Vascular Endothelial Growth Factor J. Immunol., June 15, 2005; 174(12): 7665 - 7675. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Chen, M. H. Perrin, M. R. DiGruccio, J. M. Vaughan, B. K. Brar, C. M. Arias, K. A. Lewis, J. E. Rivier, P. E. Sawchenko, and W. W. Vale A soluble mouse brain splice variant of type 2{alpha} corticotropin-releasing factor (CRF) receptor binds ligands and modulates their activity PNAS, February 15, 2005; 102(7): 2620 - 2625. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Chen, M. Perrin, B. Brar, C. Li, P. Jamieson, M. DiGruccio, K. Lewis, and W. Vale Mouse Corticotropin-Releasing Factor Receptor Type 2{alpha} Gene: Isolation, Distribution, Pharmacological Characterization and Regulation by Stress and Glucocorticoids Mol. Endocrinol., February 1, 2005; 19(2): 441 - 458. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Wietfeld, N. Heinrich, J. Furkert, K. Fechner, M. Beyermann, M. Bienert, and H. Berger Regulation of the Coupling to Different G Proteins of Rat Corticotropin-releasing Factor Receptor Type 1 in Human Embryonic Kidney 293 Cells J. Biol. Chem., September 10, 2004; 279(37): 38386 - 38394. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Parham, S. Zervou, E. Karteris, R. D. Catalano, R. W. Old, and E. W. Hillhouse Promoter Analysis of Human Corticotropin-Releasing Factor (CRF) Type 1 Receptor and Regulation by CRF and Urocortin Endocrinology, August 1, 2004; 145(8): 3971 - 3983. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Papadopoulou, J. Chen, H. S. Randeva, M. A. Levine, E. W. Hillhouse, and D. K. Grammatopoulos Protein Kinase A-Induced Negative Regulation of the Corticotropin-Releasing Hormone R1{alpha} Receptor-Extracellularly Regulated Kinase Signal Transduction Pathway: The Critical Role of Ser301 for Signaling Switch and Selectivity Mol. Endocrinol., March 1, 2004; 18(3): 624 - 639. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Slominski, A. Pisarchik, D. J. Tobin, J. E. Mazurkiewicz, and J. Wortsman Differential Expression of a Cutaneous Corticotropin-Releasing Hormone System Endocrinology, February 1, 2004; 145(2): 941 - 950. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Seck, R. Baron, and W. C. Horne The Alternatively Spliced {Delta}e13 Transcript of the Rabbit Calcitonin Receptor Dimerizes with the C1a Isoform and Inhibits Its Surface Expression J. Biol. Chem., June 13, 2003; 278(25): 23085 - 23093. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. McKeown and J. R. G. Challis Regulation of 15-Hydroxy Prostaglandin Dehydrogenase by Corticotrophin-Releasing Hormone through a Calcium-Dependent Pathway in Human Chorion Trophoblast Cells J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1737 - 1741. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Hauger, D. E. Grigoriadis, M. F. Dallman, P. M. Plotsky, W. W. Vale, and F. M. Dautzenberg International Union of Pharmacology. XXXVI. Current Status of the Nomenclature for Receptors for Corticotropin-Releasing Factor and Their Ligands Pharmacol. Rev., March 1, 2003; 55(1): 21 - 26. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Karteris, A. Goumenou, E. Koumantakis, E. W. Hillhouse, and D. K. Grammatopoulos Reduced Expression of Corticotropin-Releasing Hormone Receptor Type-1{alpha} in Human Preeclamptic and Growth-Restricted Placentas J. Clin. Endocrinol. Metab., January 1, 2003; 88(1): 363 - 370. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. W. Hillhouse, E. Karteris, K. Totsune, Y. Muramatsu, C. Kaneko, A. D. Darnel, T. Suzuki, M. Ebina, T. Nukiwa, and H. Sasano Expression of Multiple Corticotropin-Releasing Hormone Receptors in the Human Heart J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2992 - 2992. [Full Text] [PDF] |
||||
![]() |
Y. Kimura, K. Takahashi, K. Totsune, Y. Muramatsu, C. Kaneko, A. D. Darnel, T. Suzuki, M. Ebina, T. Nukiwa, and H. Sasano Authors' Response: Expression of Multiple Corticotropin-Releasing Hormone Receptors in the Human Heart J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2992 - 2993. [Full Text] [PDF] |
||||
![]() |
E. Aggelidou, E. W. Hillhouse, and D. K. Grammatopoulos Up-regulation of nitric oxide synthase and modulation of the guanylate cyclase activity by corticotropin-releasing hormone but not urocortin II or urocortin III in cultured human pregnant myometrial cells PNAS, February 14, 2002; (2002) 52296399. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. S. Randeva, E. Karteris, D. Grammatopoulos, and E. W. Hillhouse Expression of Orexin-A and Functional Orexin Type 2 Receptors in the Human Adult Adrenals: Implications for Adrenal Function and Energy Homeostasis J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4808 - 4813. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Karteris, H. S. Randeva, D. K. Grammatopoulos, R. B. Jaffe, and E. W. Hillhouse Expression and Coupling Characteristics of the CRH and Orexin Type 2 Receptors in Human Fetal Adrenals J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4512 - 4519. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. SLOMINSKI, J. WORTSMAN, A. PISARCHIK, B. ZBYTEK, E. A. LINTON, J. E. MAZURKIEWICZ, and E. T. WEI Cutaneous expression of corticotropin-releasing hormone (CRH), urocortin, and CRH receptors FASEB J, August 1, 2001; 15(10): 1678 - 1693. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. K. Grammatopoulos, H. S. Randeva, M. A. Levine, E. S. Katsanou, and E. W. Hillhouse Urocortin, but Not Corticotropin-Releasing Hormone (CRH), Activates the Mitogen-Activated Protein Kinase Signal Transduction Pathway in Human Pregnant Myometrium: An Effect Mediated via R1{{alpha}} and R2{beta} CRH Receptor Subtypes and Stimulation of Gq-Proteins Mol. Endocrinol., December 1, 2000; 14(12): 2076 - 2091. [Abstract] [Full Text] |
||||
![]() |
J. R.G. Challis, S. G. Matthews, W. Gibb, and S. J. Lye Endocrine and Paracrine Regulation of Birth at Term and Preterm Endocr. Rev., October 1, 2000; 21(5): 514 - 550. [Abstract] [Full Text] |
||||
![]() |
E. Karteris, D. Grammatopoulos, H. Randeva, and E. W. Hillhouse Signal Transduction Characteristics of the Corticotropin-Releasing Hormone Receptors in the Feto-Placental Unit J. Clin. Endocrinol. Metab., May 1, 2000; 85(5): 1989 - 1996. [Abstract] [Full Text] |
||||
![]() |
E. Aggelidou, E. W. Hillhouse, and D. K. Grammatopoulos Up-regulation of nitric oxide synthase and modulation of the guanylate cyclase activity by corticotropin-releasing hormone but not urocortin II or urocortin III in cultured human pregnant myometrial cells PNAS, March 5, 2002; 99(5): 3300 - 3305. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |